期刊首页 优先出版 当期阅读 过刊浏览 作者中心 关于期刊 English

《医学前沿(英文)》 >> 2009年 第3卷 第3期 doi: 10.1007/s11684-009-0052-3

Molecular targeted therapy of gynecological malignant tumors: the development and challenge, from laboratory to clinic

1.Institute of Gynecologic Oncology, Fujian Provincial Women and Children''s Hospital, Fujian Medical University, Fuzhou 350001, China;Department of Gynecology, Campus Virchow Klinikum, Berlin 13353, Germany; 2.Department of Gynecology, Campus Virchow Klinikum, Berlin 13353, Germany; 3.Department of Gynecology, Peking University People’s Hospital, Beijing 100044, China;

发布日期: 2009-09-05

下一篇 上一篇

摘要

More and more molecular drugs based on targeted therapy have been utilized in the treatment of gynecologic cancer, especially in ovarian cancer. In this article, we systematically review the current targeted therapeutic trials running in clinic. Large, randomized trials have been conducted in the treatment of ovarian cancer, endometrial cancer and cervical cancer by using small molecule, antisense, mutational gene as well as antibodies. Other planned or ongoing trials currentlytargeted at molecular markers which may play important roles in gynecological carcinogenesis andprogression suggest that combination chemotherapy with molecular targeted therapy will ultimately be an importantoption.

相关研究